RxDoctor Payments Data

Amy Chen, MD

Dermatology · Cromwell, CTNPI 1164681573

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 367 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations.

$8,295in general payments, 2019–2025

Across 367 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$1K
  • Johnson & Johnson$1K
  • Sanofi$476
  • Lilly USA, LLC$374
  • E.r. Squibb & Sons, L.L.C.$352
  • plus $3K from 19 others
$374,181in research payments, 2019–2025

Across 24 payments — averaging $15,591 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Incyte Corporation$374K

What the payments were for

  • Food & beverage$8,11598%
  • Education$1802%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,295 in reported general payments places this provider in the 70th percentile of 222 dermatology providers in Connecticut.

See all dermatology providers in Connecticut

Medicare billing

Part B allowed, 2024
$136,652
Medicare patients
394
Services billed
2,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab22$112,264
Fluorouracil42$2,441
Ketoconazole144$2,323
Triamcinolone Acetonide182$1,375
Metronidazole37$1,357
Halobetasol Propionate36$1,323
Nystatin63$1,152
Fluocinonide46$986
Clobetasol Propionate33$872
Cephalexin23$461
Doxycycline Monohydrate23$389
Hydrocortisone71$378
Clindamycin Phosphate15$322
Minoxidil26$280
Mupirocin22$271

Paid to pharmacies, not to this prescriber.

Other dermatology in Cromwell

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →